Alfasigma Completes License Agreement With GSK To Develop, Manufacture, Commercialise Linerixibat

Benzinga Newsdesk www.benzinga.com Neutral 84.9%

Neg 0% Neu 84.9% Pos 0%

https://www.alfasigma.com/wp-content/uploads/2026/04/Alfasigma-Completes-Agreement-with-GSK-for-linerixibat-3.pdf

Comments

No comments yet. Be the first!